Acute Porphyria Drugs

Monograph

J02AX04 - Caspofungin
Propably not porphyrinogenic
PNP

Rationale
Lipopeptide, probably not a CYP-ligand.
Chemical description
Antimycotic semisynthetic lipopeptide used in invasive candidosis and aspergilinosis, and administered as intravenous infusion 50-70 mg/d. Its metabolism is not affected by agents acting as CYP-inducers.
Similar drugs
Explore alternative drugs in similar therapeutic classes J02A / J02AX or go back.
References
Tradenames

Cancidas · Caspofungin · Caspofungine Cancidas · Caspofungin · Caspofungine Cancidas · Caspofungina · Caspofungina Idifarma Farmaceutico · Fornega · Nigufo Cancidas · Caspofungin Cancidas · Caspofungina Cancidas · Caspofungin Cancidas · Caspofungin Cancidas · Casmyg · Caspofungin · Dalvocans · Fornega Cancidas · Caspofungin Cancidas · Caspofungin Cancidas · Caspofungin · Caspofungine Cancidas · Caspofungin Cancidas · Caspofungin Cancidas · Caspofungin · Caspofungina · Dalvocans Cancidas · Caspofungin Cancidas · Caspofungin · Dalvocans Cancidas · Caspofungin · Dalvocans · Kaspofungin Cancidas · Kaspofungin Cancidas · Caspofungin Caspofungine Caspofungina Caspofungin
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙